Gilead's (GILD) Q4 earnings and sales beat on strong HIV and oncology business. The guidance for 2023 was also ahead of expectations.
The SPDR S&P 500 ETF Trust (NYSE: SPY) traded lower Friday after the Labor Department reported blowout U.S. jobs market numbers from January. The U.S. added 517,000 jobs in January, beating average ec
Trading in the U.S. index futures suggests stocks may end a solidly positive week on a negative note. That said, the data-dependency of the Fed places the onus of providing trading cues to each incomi
Gilead's strongest growth since 2015 comes with an asterisk.

Gilead (GILD) Reports Q4 Earnings: What Key Metrics Have to Say

09:26am, Friday, 03'rd Feb 2023 Zacks Investment Research
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Stree
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Stree
Gilead's strongest growth since 2015 comes with an asterisk.

Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript

02:00am, Friday, 03'rd Feb 2023 The Motley Fool
GILD earnings call for the period ending December 31, 2022.

Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates

10:35pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Gilead (GILD) delivered earnings and revenue surprises of 11.33% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Why Gilead Sciences Stock Is Trading Higher After Hours

10:27pm, Thursday, 02'nd Feb 2023 Benzinga
Gilead Sciences Inc (NASDAQ: GILD) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected results, issued strong guidance, and raised its dividen
Gilead Sciences, Inc. (NASDAQ:GILD ) Q4 2022 Earnings Conference Call February 2, 2023 4:30 PM ET Company Participants Jacquie Ross - VP, IR Daniel O'Day - Chairman and CEO Johanna Mercier - Chief Com
Gilead (GILD) delivered earnings and revenue surprises of 11.33% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Shares of Gilead Sciences Inc. GILD, -3.11% rose more than 5% in the extended session Thursday after the pharma company reported fourth-quarter earnings and sales above Wall Street expectations, sayin
In our call of the day, LaDuc says cash is the place to be and that investors are "being paid to wait. They're getting very favorable 4.5% on their sitting cash."
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. Meta Platform Inc’s (NASDAQ: META) strong earnings could set the tempo for the market mood as tr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE